39 Results (Page 1 of 4)
Pharmaceuticals Free Markets Research Reports
Australia Lung Cancer Drugs Market Analysis Sample Report
Lung cancer is the fifth most common type of cancer affecting the Australian population, therefore the Australia lung cancer drugs market is projected to grow during the forecast period. The market is segmented by type, treatment, end user, route of administration, and distribution channel.
Australia Primary Hyperoxaluria (PH) Market Analysis Sample Report
Australia Primary Hyperoxaluria (PH) market stood at around $2.1 Mn in 2022 and is projected to reach $8.8 Mn with a CAGR of 19% for the year 2022-2030. The market is segmented by type, diagnosis, drug, treatment and by distribution channel. Alnylam Pharmaceuticals and Dicerna Pharmaceuticals are some of the key players in the Australia PH market.
Australia Sickle Cell Disease Market Analysis Sample Report
Australia Sickle Cell Disease market is expected to grow from $1.1 Mn in 2022 to $2.6 Mn in 2030 with a CAGR of 11% for the year 2022 to 2030. The market is segmented by treatment modality and by distribution channel. Novartis and AstraZeneca are some of the key players in the Australia sickle cell disease market.
Canada Cannabis for GI Disease Market Analysis Sample Report
The legalization of medical cannabis in Canada has resulted in the growth of Canada cannabis for GI diseases market. Cannabis can be used to treat irritable bowel disease, inflammatory bowel diseases, and colitis. The market is segmented by application and by product type.
Canada Dermatology Market Analysis Sample Report
Canada dermatology market is projected to grow from $2.78 Bn in 2022 to $5.31 Bn in 2030 with a CAGR of 8.44% for the year 2022-2030. More Canadians investing in skincare solutions is driving the Canada dermatology market. Major dermatological disorders in Canada are alopecia and psoriasis.
Canada Pharmacy Market Analysis Sample Report
The Canada pharmacy market is expected to witness growth from $83.08 Bn in 2022 to $141.69 Bn in 2030 with a CAGR of 6.9% for the year 2022-2030. Major market drivers include increasing health expenditure and a rise in per capita disposable income. The market is segmented by industry products and services and by pharmacy groups.
China Antiepileptics Drugs Market Analysis Sample Report
The China antiepileptics drugs market stood at around $0.82 Bn in 2022 and is projected to reach $1.32 Bn in 2030 with a CAGR of 2.3% for the year 2022-2030. Valproic acid and Lamotrigine are the top selling antiepileptic drugs in China. The market is segmented by generation and by distribution channel.
China Dermatology Therapeutics Market Analysis Sample Report
The China dermatology therapeutics market is projected to grow from $2.79 Bn in 2022 to $5.96 Bn in 2030 with a CAGR of 9.94% for the year 2022-2030. As China is one of the countries with a lot of focus on skin-related disorders and skincare routines, the market is projected to grow during the forecast period.
China Psoriasis Market Analysis Sample Report
The increase in healthcare expenditure and the introduction of novel treatments for psoriasis in China are causing the China psoriasis market to grow during the forecast period. Major diseases in China include plaque psoriasis, nail psoriasis, and guttate psoriasis. The market is segmented by drug class, distribution channel, and route of administration.
Egypt Anti-Aging Market Analysis Sample Report
The Egypt anti-aging market is expected to grow from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The consistent demand for anti-wrinkle products for aging people across Egypt is driving the growth of the market. Alma Lasers and Beiersdorf are the key players in the market.
Egypt Contraceptive Market Analysis Sample Report
The Egypt contraceptive market will grow as a result of rising awareness of sexual health in Egypt. Long-lasting vaginal rings and fertility-tracking apps are some of the new contraceptive innovations used in Egypt. The market is segmented by drug type, medical devices, and by end users.
Germany Chronic Obstructive Pulmonary Disease (COPD) Market Analysis Sample Report
Tobacco smoke and inhalation of heavily contaminated dust are some of the major reasons responsible for the development of COPD in Germany. The Germany COPD market is projected to grow as a result of increasing incidences of COPD in Germany. The market is segmented by treatment type, drug class, and by distribution channel.